Anti-malarial effect of novel chloroquine derivatives as agents for the treatment of malaria

Malaria Journal

Volumn 16, Issue 1, 2017, Pages

  Yeo, Seon Ju ^a   Liu, Dong Xu ^a   Kim, Hak Sung ^a   Park, Hyun ^a  

^a Wonkwang University   (South Korea)

Author keywords

Anti malarial efficacy; Chloroquine derivatives; SKM13; , unsaturated amides

Indexed keywords

AMIDE; ATOVAQUONE; CHLOROQUINE; CHLOROQUINE SKM 13; DIETHEYL [2 [[2 (DIMETHYLAMINO)ETHYL](METHYL)AMINO] 2 OXOETHYL]PHOSPHONATE; DIETHYL [2 [[3 (DIMETHYLAMINO)PROPYL]AMINO] 2 OXOETHYL]PHOSPHONATE; HEMOGLOBIN; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; ERYTHROCYTE COUNT; FEMALE; GROWTH INHIBITION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; IN VIVO STUDY; MALARIA; MICROBIAL GROWTH; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; SURVIVAL RATE; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; MALARIA FALCIPARUM;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALARIA; MALARIA, FALCIPARUM; MICE; MICE, INBRED ICR; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

EID: 85013080679     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-017-1725-z     Document Type: Article

References (35)

1. Roll Back Malaria. World malaria report 2005. Geneva: World Health Organization and UNICEF; 2005. http://www.who.int/malaria/publications/atoz/9241593199/en/.
2. CDC. Malaria; 2015. https://www.cdc.gov/malaria/.
3. Schellenberg D, Abdulla S, Roper C. Current issues for anti-malarial drugs to control P. falciparum malaria. Curr Mol Med. 2006;6:253-60.
4. Slater AF. Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacol Ther. 1993;57:203-35.
5. Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J. 2011;10:144.
6. CDC. Drug resistance in the malaria-endemic world; 2015. https://www.cdc.gov/malaria/malaria_worldwide/reduction/drug_resistance.html.
7. Diagana TT. Supporting malaria elimination with 21st century anti-malarial agent drug discovery. Drug Discov Today. 2015;20:1265-70.
8. Chou AC, Chevli R, Fitch CD. Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry. 1980;19:1543-9.
9. Saliba KJ, Folb PI, Smith PJ. Role for the Plasmodium falciparum digestive vacuole in chloroquine resistance. Biochem Pharmacol. 1998;56:313-20.
10. Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today’s diseases? Lancet Infect Dis. 2003;3:722-7.
11. Yan Y, Zou Z, Sun Y, Li X, Xu KF, Wei Y, Jin N, Jiang C. Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Res. 2013;23:300-2.
12. Sotelo J, Briceno E, Lopez-Gonzalez MA. Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2006;144:337-43.
13. Chen PM, Gombart ZJ, Chen JW. Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration. Cell Biosci. 2011;1:10.
14. Hawkes M, Conroy AL, Kain KC. Spread of artemisinin resistance in malaria. N Engl J Med. 2014;371:1944-5.
15. Ajayi NA, Ukwaja KN. Possible artemisinin-based combination therapy-resistant malaria in Nigeria: a report of three cases. Rev Soc Bras Med Trop. 2013;46:525-7.
16. Malhotra R, Mutreja D. A case of complicated falciparum malaria with treatment failure to artemisinin combination therapy. J Assoc Physicians India. 2014;62:861-3.
17. Andrews S, Burgess SJ, Skaalrud D, Kelly JX, Peyton DH. Reversal agent and linker variants of reversed chloroquines: activities against Plasmodium falciparum. J Med Chem. 2010;53:916-9.
18. Ekoue-Kovi K, Yearick K, Iwaniuk DP, Natarajan JK, Alumasa J, de Dios AC, Roepe PD, Wolf C. Synthesis and anti-malarial activity of new 4-amino-7-chloroquinolyl amides, sulfonamides, ureas and thioureas. Bioorg Med Chem. 2009;17:270-83.
19. Ryckebusch A, Debreu-Fontaine MA, Mouray E, Grellier P, Sergheraert C, Melnyk P. Synthesis and anti-malarial evaluation of new N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives. Bioorg Med Chem Lett. 2005;15:297-302.
20. Russo I, Oksman A, Vaupel B, Goldberg DE. A calpain unique to alveolates is essential in Plasmodium falciparum and its knockdown reveals an involvement in pre-S-phase development. Proc Natl Acad Sci USA. 2009;106:1554-9.
21. Choi HJ, Cui M, Li DY, Song HO, Kim HS, Park H. Anti-malarial activity of new N-acetyl-L-leucyl-L-leucyl-L-norleucinal (ALLN) derivatives against Plasmodium falciparum. Bioorg Med Chem Lett. 2013;23:1293-6.
22. Mallik SK, Li DY, Cui M, Song HO, Park H, Kim HS. Synthesis and evaluation of peptidyl alpha, beta-unsaturated carbonyl derivatives as anti-malarial calpain inhibitors. Arch Pharm Res. 2012;35:469-79.
23. Cheng J, Zeidan R, Mishra S, Liu A, Pun SH, Kulkarni RP, Jensen GS, Bellocq NC, Davis ME. Structure-function correlation of chloroquine and analogues as transgene expression enhancers in nonviral gene delivery. J Med Chem. 2006;49:6522-31.
24. Kim J-G, Jang DO. A convenient one-pot method for the synthesis of N-methoxy-N-methyl amides from carboxylic acids. Bull Korean Chem Soc. 2010;31:171-3.
25. Paris M, Pothien C, Goulleux L, Heitz A, Martineza J, Fehrentza J-A. Synthesis of peptide aldehydes on solid support. React Funct Polym. 1999;41:255-61.
26. Ando KA. Mechanistic study of the Horner-Wadsworth-Emmons reaction: computational investigation on the reaction pass and the stereochemistry in the reaction of lithium enolate derived from trimethyl phosphonoacetate with acetaldehyde. J Org Chem. 1999;64:6815-21.
27. Yeo SJ, Huong DT, Han JH, Kim JY, Lee WJ, Shin HJ, et al. Performance of coumarin-derived dendrimer-based fluorescence-linked immunosorbent assay (FLISA) to detect malaria antigen. Malar J. 2014;13:266.
28. Ekengard E, Glans L, Cassells I, Fogeron T, Govender P, Stringer T, et al. Anti-malarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands. Dalton Trans. 2015;44:19314-29.
29. Kotepui M, Piwkham D, PhunPhuech B, Phiwklam N, Chupeerach C, Duangmano S. Effects of malaria parasite density on blood cell parameters. PLoS ONE. 2015;10:e0121057.
30. Taconic. Phenotypic data of ICR; 2003. http://www.taconic.com/mouse-model/icr.
31. Basco LK, Dechy-Cabaret O, Ndounga M, Meche FS, Robert A, Meunier B. In vitro activities of DU-1102, a new trioxaquine derivative, against Plasmodium falciparum isolates. Antimicrob Agents Chemother. 2001;45:1886-8.
32. Muregi FW, Ishih A. Next-generation anti-malarial drugs: hybrid molecules as a new strategy in drug design. Drug Dev Res. 2010;71:20-32.
33. Pagola S, Stephens PW, Bohle DS, Kosar AD, Madsen SK. The structure of malaria pigment beta-haematin. Nature. 2000;404:307-10.
34. Chiyanzu I, Clarkson C, Smith PJ, Lehman J, Gut J, Rosenthal PJ, et al. Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives. Bioorg Med Chem. 2005;13:3249-61.
35. Erhart LM, Yingyuen K, Chuanak N, Buathong N, Laoboonchai A, Miller RS, et al. Hematologic and clinical indices of malaria in a semi-immune population of western Thailand. Am J Trop Med Hyg. 2004;70:8-14.